webinar register page

Webinar banner
Cancer Center Updates On: Clinical Trials Tuesday, December 14th at 12pm PST
Join our Updates On: Clinical Trials webinar featuring leading Cancer Physician Dr. Keith T. Flaherty, M.D. and Sanford Burnham Prebys Cancer Center Director, Dr. Ze'ev Ronai. Moderating the event is Steven Silverstein, a Cancer Survivor and Chair Emeritus of the Melanoma Research Foundation.

Keith T. Flaherty, M.D.
Director of Clinical Research, MGH Cancer Center
Professor of Medicine, Harvard Medical School

Ze'ev Ronai, Ph.D.
Director and Professor,
NCI-Designated Cancer Center
Sanford Burnham Prebys
Jeanne and Gary Herberger
Leadership Chair in Cancer Research

Steven Silverstein, M.B.A.
Chair Emeritus, Board of Directors
Melanoma Research Foundation

Dec 14, 2021 12:00 PM in Pacific Time (US and Canada)

Webinar logo
* Required information


Keith T. Flaherty, M.D.
Director of Clinical Research, MGH Cancer Center, Professor of Medicine, Harvard Medical School @MGH Cancer Center, Harvard Medical School
Dr. Flaherty is Director of Clinical Research at the Massachusetts General Hospital Cancer Center, and Professor of Medicine at Harvard Medical School. As described in the more than 300 peer reviewed primary research reports he has authored or co-authored, Dr. Flaherty and colleagues made several seminal observations that have defined the treatment of melanoma when they established the efficacy of BRAF, MEK and combined BRAF/MEK inhibition in patients with metastatic melanoma in a series of New England Journal of Medicine articles for which Dr. Flaherty was the first or senior author. Dr. Flaherty also has been a leader in assessing and identifying mechanisms of de novo and acquired resistance to BRAF inhibitor therapy and clinically evaluating next generation inhibitors, work that has had implications for resistance to targeted therapy regimens used to treat other malignant diseases.
Ze'ev Ronai, Ph.D.
Director & Professor, NCI-Designated Cancer Center @Sanford Burnham Prebys
Steven Silverstein
HOST/MODERATOR: Cancer Survivor, Chief Emeritus, Board of Directors, @Melanoma Research Foundation